Epidemiology of Renal Cell Carcinoma: 2022 Update

Laura Bukavina 1, Karim Bensalah 2, Freddie Bray 3, Maria Carlo 4, Ben Challacombe 5, Jose A Karam 6, Wassim Kassouf 7, Thomas Mitchell 8, Rodolfo Montironi 9, Tim O’Brien 5, Valeria Panebianco 10, Ghislaine Scelo 11, Brian Shuch 12, Hein van Poppel 13, Christopher D Blosser 14, Sarah P Psutka 15
Affiliations Expand
PMID: 36100483 DOI: 10.1016/j.eururo.2022.08.019

Abstract

Context: International variations in the rates of kidney cancer (KC) are considerable. An understanding of the risk factors for KC development is necessary to generate opportunities to reduce its incidence through prevention and surveillance.

Objective: To retrieve and summarize global incidence and mortality rates of KC and risk factors associated with its development, and to describe known familial syndromes and genetic alterations that represent biologic risk factors.

Evidence acquisition: A systematic review was conducted via Medline (PubMed) and Scopus to include meta-analyses, reviews, and original studies regarding renal cell carcinoma, epidemiology, and risk factors.

Evidence synthesis: Our narrative review provides a detailed analysis of KC incidence and mortality, with significant variations across time, geography, and sex. In particular, while KC incidence has continued to increase, mortality models have leveled off. Among the many risk factors, hypertension, obesity, and smoking are the most well established. The emergence of new genetic data coupled with observational data allows for integrated management and surveillance strategies for KC care.

Conclusions: KC incidence and mortality rates vary significantly by geography, sex, and age. Associations of the development of KC with modifiable and fixed risk factors such as obesity, hypertension, smoking, and chronic kidney disease (CKD)/end-stage kidney disease (ESKD) are well described. Recent advances in the genetic characterization of these cancers have led to a better understanding of the germline and somatic mutations that predispose patients to KC development, with potential for identification of therapeutic targets that may improve outcomes for these at-risk patients.

Patient summary: We reviewed evidence on the occurrence of kidney cancer (KC) around the world. Currently, the main avoidable causes are smoking, obesity, and high blood pressure. Although other risk factors also contribute, prevention and treatment of these three factors provide the best opportunities to reduce the risk of developing KC at present.

Keywords: Epidemiology; Kidney cancer; Renal cell carcinoma; Risk factors; Tumors of the kidney.

PubMed Disclaimer

Similar articles

  • Epidemiology of Renal Cell Carcinoma.

    Capitanio U, Bensalah K, Bex A, Boorjian SA, Bray F, Coleman J, Gore JL, Sun M, Wood C, Russo P.Eur Urol. 2019 Jan;75(1):74-84. doi: 10.1016/j.eururo.2018.08.036. Epub 2018 Sep 19.PMID: 30243799 Free PMC article. Review.
  • Epidemiology of renal cell cancer.

    Cho E, Adami HO, Lindblad P.Hematol Oncol Clin North Am. 2011 Aug;25(4):651-65. doi: 10.1016/j.hoc.2011.04.002.PMID: 21763961 Review.
  • Epidemiology and risk factors for kidney cancer.

    Chow WH, Dong LM, Devesa SS.Nat Rev Urol. 2010 May;7(5):245-57. doi: 10.1038/nrurol.2010.46.PMID: 20448658 Free PMC article. Review.
  • Contemporary epidemiology of renal cell cancer.

    Chow WH, Devesa SS.Cancer J. 2008 Sep-Oct;14(5):288-301. doi: 10.1097/PPO.0b013e3181867628.PMID: 18836333 Free PMC article.
  • Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention.

    Weikert S, Ljungberg B.World J Urol. 2010 Jun;28(3):247-52. doi: 10.1007/s00345-010-0555-1.PMID: 20390283 Review.
See all similar articles

Cited by

  • Retrospective Multicenter Analysis of Prognostic Risk Factors for One Year Recurrence in Patient With Renal Cell Carcinoma After Partial or Radical Nephrectomy: Results of Korean Renal Cancer Study Group (KRoCS) Database.

    Choi C, Kang M, Seo SI, Suh J, Song C, Chung J, Kim SH, Park JY, Hwang EC, Jeong CW, Kwak C, Kim JK, Hong SH.J Korean Med Sci. 2024 Jan 22;39(3):e11. doi: 10.3346/jkms.2024.39.e11.PMID: 38258358 Free PMC article.
  • Surgical Trends and Complications in Partial and Radical Nephrectomy: Results from the GRAND Study.

    Pyrgidis N, Schulz GB, Stief C, Blajan I, Ivanova T, Graser A, Staehler M.Cancers (Basel). 2023 Dec 24;16(1):97. doi: 10.3390/cancers16010097.PMID: 38201523 Free PMC article.
  • Methuosis Inducer SGI-1027 Cooperates with Everolimus to Promote Apoptosis and Pyroptosis by Triggering Lysosomal Membrane Permeability in Renal Cancer.

    Luo Y, Guan B, Deng X, Bai P, Huang H, Miao C, Sun A, Li Z, Yang D, Wang X, Shao Z, Wu Y, Xing J, Chen B, Wang T.Adv Sci (Weinh). 2024 Oct;11(38):e2404693. doi: 10.1002/advs.202404693. Epub 2024 Aug 9.PMID: 39119834 Free PMC article.
  • Low Serum Alanine Aminotransferase Blood Activity Is Associated with Shortened Survival of Renal Cell Cancer Patients and Survivors: Retrospective Analysis of 1830 Patients.

    Laufer M, Sarfaty M, Jacobi E, Itelman E, Segal G, Perelman M.J Clin Med. 2024 Oct 7;13(19):5960. doi: 10.3390/jcm13195960.PMID: 39408021 Free PMC article.
  • Single-cell combined bioinformatics analysis: construction of immune cluster and risk prognostic model in kidney renal clear cells based on CD8+ T cell-associated genes.

    Gao H, Sun H, He A, Liu H, Zhang Z, Li D, Mao W, Qian J.Eur J Med Res. 2024 Jan 30;29(1):89. doi: 10.1186/s40001-024-01689-8.PMID: 38291496 Free PMC article.

Leave a Reply

Your email address will not be published. Required fields are marked *